IndraLab
Statements
reach
"Because IL-6 has been found to increase the levels of serine pSTAT3 and induce the phosphorylation of STAT3 on tyrosine residues XREF_BIBR, we incubated CLL cells with 30 mg/ml rhIL-6 for 20 minutes and analyzed their miR-155 expression levels at different times following incubation using RT-PCR and relative qRT-PCR."
reach
"To inhibit STAT3 activity, we utilized C188-9, a specific STAT3 inhibitor.28, 33, 34 As expected, C188-9 treatment reduced the tyrosine phosphorylated levels of STAT3 (Y705) in both two cell lines whereas IL-6, a known STAT3 activator, stimulated the tyrosine phosphorylation of STAT3."
| PMC
reach
"Targeting IL-6 and IL-6 receptor using monoclonal antibodies Siltuximab and Tocilizumab in a K-ras mutant mouse model for lung cancer suppressed cancer progression via inhibition of STAT3 tyrosine phosphorylation (86,87) and polarized macrophages towards an anti-tumor phenotype (87)."
reach
"We reported recently that angiotensin II (AII) and phorbol 12-myristate 13-acetate (PMA) transiently inhibit interleukin 6 (IL-6)-stimulated tyrosine phosphorylation of signal transducers and activators of transcription 3 (Stat3) and subsequent formation of sis inducing factor-A (SIF-A)."
reach
"IL-6 increased phosphorylation of STAT3 (at Tyr (705)) and ERK1/2 (at Tyr (204)) within 5 min that peaked at 15-30 min and returned to basal levels at 2 h. Phosphorylation of STAT3 was blocked by genistein, a protein tyrosine kinase inhibitor, and AG490, a JAK2 inhibitor, but not PD98059, an ERK1/2 kinase inhibitor."